Abstract:Objective: To explore the therapeutic effect and mechanism of triptolide on membranous neph ropathy using passive Heymann nephritis (PHN) in rats. Methodology: Passive Heymann nephritis was induced in SD rats using rabbit antiserum against FxIA antigen. SD rats were divided into three groups, including normal controls, PHN rats with or without treatment with triptolide. PHN rats were administrated orally with triptolide (200 μg/kg per day). After the treatment with triptolid e for 7, 14, 21 and 28 days,the 24hr urine and blood were collected to examine the levels of proteinuria, serum albumin, aminotransferases, serum creatinine an d white blood cell counts. The renal tissue was processed for the examinations o f light microscopy, electron microscopy, immunefluorescene and immune electron m icroscopy. The deposition of IgG and C5b-9 along capillary wall was observed. T he distribution of nephrin and podocin as the expression of slit diaphragm prote ins was also determined. Results: (1) Urinary protein: Triptolide could significantly reduce proteinuria in rats with passive Heymann nephritis. This effect could be seen at day 7 after the tre atment and got more prominent at day 14 and persistent on day 21 and 28. At the same time, the plasma albumin was also significantly increased(P<0.01). ( 2) Subepithelial immune deposits: The examination of electron microscopy showed that the subepithelial immune deposits, spikes formation and basement membrane proliferation were improved after treatment with triptolide. The subepithelial i mmune deposits decreased and the reaction of basement membrane was also ameliora ted. However, the subepithelial immune deposits still existed although the urina ry protein decreased significantly. (3) Glomerular deposition of IgG and C5b-9: The immunefluorescene observation indicated that the deposition of IgG and C5b -9 decreased after treatment with triptolide. Compared with Heymann nephritis, the intensity of fluorescene decreased, especially after treatment with triptoli de for 7 days. (4) Injuries on podocytes: After treatment with triptolide for 7, 14, 21 and 24 days, the injuries on foot process of podocyte were recovered com pared with that in Heymann nephritis. The effacement of the podocyte foot proces ses was improved. The mean width of foot processes was decreased. Most foot proc esses was restored to normal shape after treatment with triptolide for 28 days. (5) Change of slit diaphragm related protein: After treatment with triptolide fo r 7 days, the expression of nephrin and podocin was significantly increased comp ared with that in Heymann nephritis. The abnormal distribution of nephrin and po docin started to be corrected. After treatment with triptolide for 21 days, the expression of nephrin and podocin was mostly restored to normal continuous linea r expression. The immune electron microscopy confirmed the therapeutic effect of triptolide on the restoration of nephrin expression. Conclusion: Triptolide could effectively reduce proteinuria and alleviate the glomerular imm une injuries, and also remarkably improve the podocyte lesion and help to restor e the normal structure of slit diaphragm. In addition to its immunosuppression a nd anti-inflammation activity, the therapeutic effect of triptolide might be du e to its direct activity on the treatment with podocyte injuries.

Triptolide alters barrier function in renal proximal tubular cells in rats

&lt;i&gt;In Vitro&lt;/i&gt; Study of the Nephrotoxicity of Tripterygium Tablet Extract and Triptolide in Monolayer HK-2 Cells Cultured in a Transwell Chamber

Triptolide Inhibits Proinflammatory Factor-Induced Over-Expression of Class Ii Mhc and B7 Molecules in Renal Tubular Epithelial Cells

Triptolide exposure triggers testicular vacuolization injury by disrupting the Sertoli cell junction and cytoskeletal organization via the AKT/mTOR signaling pathway

Male Reproductive Toxicity and Toxicokinetics of Triptolide in Rats

Triptolide Induces hepatotoxicity via inhibition of CYP450s in Rat liver microsomes

The Subacute Renal Toxicity of Triptolide in Wistar Rats

Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.

Therapeutic effect of triptolide on podocyte injury in passive Heymann nephritis

The role of breast cancer resistance protein (Bcrp/Abcg2) in triptolide-induced testis toxicity

Heat Shock Protein 72 Protects Kidney Proximal Tubule Cells From Injury Induced By Triptolide By Means Of Activation Of The Mek/Erk Pathway

Effect of Triptolide on Expression of Thrombospondin-1 and Transforming Growth Factor-Β1 in Renal Tubular Cells

Triptolide Down-Regulates Tumor Necrosis Factor-Α and Interferon-Γ-induced Overexpression of Monocyte Chemoattractant Protein-1 in Human Proximal Tubular Epithelial Cells

Involvement of oxidative stress in the mechanism of triptolide-induced acute nephrotoxicity in rats

Triptolide Attenuates Podocyte Injury by Regulating Expression of Mirna-344B-3p and Mirna-30B-3p in Rats with Adriamycin-Induced Nephropathy

Altered integrity of hepatocyte tight junctions in rats with triptolide-induced cholestasis

Triptolide Induces Adverse Effect on Reproductive Parameters of Female Sprague-Dawley Rats

Therapeutic effect of triptolide on podocyte injury in nephrosis rats induced by puromycin aminonucleoside

Triptolide induces oxidative damage in NRK-52E cells through facilitating Nrf2 degradation by ubiquitination via the GSK-3β/Fyn pathway

Triptolid ameliorate podocyte injury induced by puro mycin aminonucleoside in vitro

Involvement of Mitochondrial Pathway in Triptolide-Induced Cytotoxicity in Human Normal Liver L-02 Cells